IBDEI2H1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39465,0)
 ;;=N52.33^^152^1997^42
 ;;^UTILITY(U,$J,358.3,39465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39465,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,39465,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,39465,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,39466,0)
 ;;=N52.32^^152^1997^39
 ;;^UTILITY(U,$J,358.3,39466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39466,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,39466,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,39466,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,39467,0)
 ;;=N52.31^^152^1997^40
 ;;^UTILITY(U,$J,358.3,39467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39467,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,39467,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,39467,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,39468,0)
 ;;=N52.2^^152^1997^46
 ;;^UTILITY(U,$J,358.3,39468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39468,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,39468,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,39468,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,39469,0)
 ;;=N52.03^^152^1997^37
 ;;^UTILITY(U,$J,358.3,39469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39469,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,39469,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,39469,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,39470,0)
 ;;=N52.02^^152^1997^38
 ;;^UTILITY(U,$J,358.3,39470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39470,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,39470,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,39470,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,39471,0)
 ;;=N52.1^^152^1997^45
 ;;^UTILITY(U,$J,358.3,39471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39471,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,39471,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,39471,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,39472,0)
 ;;=N52.01^^152^1997^44
 ;;^UTILITY(U,$J,358.3,39472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39472,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,39472,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,39472,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,39473,0)
 ;;=N95.2^^152^1997^88
 ;;^UTILITY(U,$J,358.3,39473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39473,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,39473,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,39473,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,39474,0)
 ;;=R30.9^^152^1997^69
 ;;^UTILITY(U,$J,358.3,39474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39474,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,39474,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,39474,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,39475,0)
 ;;=R30.0^^152^1997^28
 ;;^UTILITY(U,$J,358.3,39475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39475,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,39475,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,39475,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,39476,0)
 ;;=R33.9^^152^1997^119
 ;;^UTILITY(U,$J,358.3,39476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39476,1,3,0)
 ;;=3^Urine Retention,Unspec
 ;;^UTILITY(U,$J,358.3,39476,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,39476,2)
 ;;=^5019332
